Lenalidomide for treatment of recurrent oral aphthae in Adamantiades-Behcet's disease

被引：2
作者：
Ossorio-Garcia, Lidia [1 ]
Jimenez-Gallo, David [1 ]
de la Varga-Martinez, Raquel [2 ]
Linares-Barrios, Mario [1 ]
机构：
[1] Hosp Univ Puerta del Mar, Unidad Gest Clin Dermatol, Cadiz, Andalusia, Spain
[2] Hosp Univ Puerta del Mar, Area Invest Clin Inmunol & Reumatol, Unidad Invest, Cadiz, Andalusia, Spain
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2018年 / 16卷 / 08期
关键词：
MUCOCUTANEOUS LESIONS; MANAGEMENT;
D O I：
10.1111/ddg.13602
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1029 / 1031
页数：3
相关论文
共 10 条
  • [1] Alpsoy E, 2005, CLIN EXP RHEUMATOL, V23, P532
  • [2] Behcet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions
    Alpsoy, Erkan
    [J]. JOURNAL OF DERMATOLOGY, 2016, 43 (06) : 620 - 632
  • [3] Non-infectious ulcerating oral mucous membrane diseases
    Altenburg, Andreas
    Krahl, Dieter
    Zouboulis, Christos C.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 (03): : 242 - 255
  • [4] The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria
    Davatchi, F.
    Assaad-Khalil, S.
    Calamia, K. T.
    Crook, J. E.
    Sadeghi-Abdollahi, B.
    Schirmer, M.
    Tzellos, T.
    Zouboulis, C. C.
    Akhlagi, M.
    Al-Dalaan, A.
    Alekberova, Z. S.
    Ali, A. A.
    Altenburg, A.
    Arromdee, E.
    Baltaci, M.
    Bastos, M.
    Benamour, S.
    Ben Ghorbel, I.
    Boyvat, A.
    Carvalho, L.
    Chen, W.
    Ben-Chetrit, E.
    Chams-Davatchi, C.
    Correia, J. A.
    Crespo, J.
    Dias, C.
    Dong, Y.
    Paixao-Duarte, F.
    Elmuntaser, K.
    Elonakov, A. V.
    Grana Gil, J.
    Haghdoost, A-A.
    Hayani, R. M.
    Houman, H.
    Isayeva, A. R.
    Jamshidi, A. R.
    Kaklamanis, P.
    Kumar, A.
    Kyrgidis, A.
    Madanat, W.
    Nadji, A.
    Namba, K.
    Ohno, S.
    Olivieri, I.
    Vaz Patto, J.
    Pipitone, N.
    de Queiroz, M. V.
    Ramos, F.
    Resende, C.
    Rosa, C. M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (03) : 338 - 347
  • [5] Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease
    Direskeneli, H.
    Ergun, T.
    Yavuz, S.
    Hamuryudan, V.
    Eksioglu-Demiralp, E.
    [J]. CLINICAL RHEUMATOLOGY, 2008, 27 (03) : 373 - 375
  • [6] Deep abdominal wall ulceration in a patient with Behcet's disease
    El-Haj, Nadine
    Zouboulis, Christos C.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 (03): : 235 - 236
  • [7] Successful treatment of Behcet's disease with lenalidomide
    Green, J.
    Upjohn, E.
    McCormack, C.
    Zeldis, J.
    Prince, H. M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (01) : 197 - 198
  • [8] Successful Management of Refractory Pediatric-Onset Complex Aphthosis With Lenalidomide
    Kalampokis, Ioannis
    Rabinovich, C. Egla
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (04) : 221 - 223
  • [9] Interventions for the management of oral ulcers in Behcet's disease
    Taylor, Jennifer
    Glenny, Anne-Marie
    Walsh, Tanya
    Brocklehurst, Paul
    Riley, Philip
    Gorodkin, Rachel
    Pemberton, Michael N.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09):
  • [10] Behcet's disease physiopathology: a contemporary review
    Zeidan, Mohamad J.
    Saadoun, David
    Garrido, Marlene
    Klatzmann, David
    Six, Adrien
    Cacoub, Patrice
    [J]. AUTOIMMUNITY HIGHLIGHTS, 2016, 7 (01) : 1 - 12
1